GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.83629 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9 |
8.89022 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FABP3, FABP4, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B1, HSD17B2, KDR, MET, PPARA, SERPINE1, SLC1A1, SRC, XDH |
8.65275 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.92666 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AR, AXL, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, GPER1, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PPARA, SERPINE1, SRC, TYR |
7.75731 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, PIM1, PPARA, TYR, XDH |
6.96806 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.89891 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
6.73334 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.59151 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.59151 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AR, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PPARA, SERPINE1, SRC, TYR |
6.53178 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, HSD17B1, HSD17B2 |
6.35892 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
6.16284 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA, SLC1A1 |
6.14352 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.75185 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SERPINE1, SRC, XDH |
5.56569 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SERPINE1, SRC, XDH |
5.45624 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, SRC |
5.41308 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.40678 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AR, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, SERPINE1, SRC, TYR |
5.3747 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CYP1B1, ESR1, F3, FLT3, GPER1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SRC, XDH |
5.36988 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AR, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, GPER1, GRM1, HCAR2, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.3494 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPER1, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SRC, XDH |
5.33499 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AR, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, GPER1, GRM1, HCAR2, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.33499 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.30142 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, GPER1, HCAR2, HSD17B1, HSD17B2 |
5.29193 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, SERPINE1, SRC, TYR |
5.29193 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
5.29193 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CYP1B1, ESR1, F3, FLT3, GPER1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SERPINE1, SRC, XDH |
5.29193 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.24024 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SLC1A1, SRC, XDH |
5.14924 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA, SLC1A1 |
5.02067 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
4.96564 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, GPER1, GRM1, GRM3, GRM5, GRM8 |
4.76188 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CYP1B1, ESR1, F3, FLT3, GPER1, GRIK5, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SERPINE1, SRC, XDH |
4.71105 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
4.64187 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
4.56461 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AR, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, GPER1, SRC, TYR |
4.50686 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AR, AXL, CYP1B1, DRD2, F10, F3, FLT3, GPER1, GRM1, KDR, MET, PTPN1, SRC, XDH |
4.50686 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.48202 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AR, CA2, CA9, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GPER1, GRM5, IGF1R, MMP2, PPARA, SRC |
4.48202 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, AR, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.45351 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, AR, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.39998 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F10, F3, FABP4, GPER1, GRM1, GRM5, GRM8, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TYR |
4.38878 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, AXL, CYP1B1, DRD1, ESR1, GPER1, GRIK5, GRM5, IGF1R, MMP2, MMP9, SERPINE1, SRC |
4.34756 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, GPER1, GRM1, GRM3, GRM5, GRM8 |
4.32186 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
4.27712 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
4.26719 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.26719 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
4.26153 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AR, CDC25B, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
4.24267 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, SERPINE1, SRC |
4.19939 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, AXL, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, MET, SRC |
4.07407 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.06499 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AR, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, IGF1R, KDR, MMP2, SERPINE1, SRC |
4.05703 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, GPER1, KDR, SRC |
3.96659 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F10, F3, GPER1, MET, SRC, XDH |
3.92397 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, AR, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
3.92372 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, AR, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
3.92372 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FUT7, MET, PPARA |
3.92047 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AR, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, GRIK5, GRM5, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SERPINE1, SRC |
3.92047 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.72449 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
3.6919 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.67154 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.61973 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AR, AURKB, AXL, CYP1B1, DRD2, ESR1, F10, F3, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.60352 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.6028 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.6028 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.58054 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2 |
3.58054 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.55958 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, AR, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.54088 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AR, CA2, CA9, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, PPARA, SRC |
3.47786 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.44825 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
3.4186 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PTPN1, SERPINE1, SRC |
3.40419 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AR, AXL, CA1, CA2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC |
3.38674 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, GPER1, GRIK5, GRM1, GRM5, MET |
3.35108 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AR, AURKB, AXL, CA2, CA6, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTPN1, SERPINE1, SRC, TYR |
3.33742 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SRC |
3.32088 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
3.30235 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, GPER1 |
3.25289 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.2469 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
3.21157 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.18572 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, GPER1, HCAR2, KDR, SRC |
3.18572 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, AR, CDC25B, DRD2, ESRRB, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
3.15654 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.15654 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.15654 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.13412 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TYR, XDH |
3.11308 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, SERPINE1, SRC |
3.1024 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AR, AXL, CYP1B1, DRD2, ESRRA, F10, F3, FABP4, FLT3, GPER1, GRM1, KDR, MET, MMP2, MMP9, PTPN1, SERPINE1, SRC, XDH |
3.1024 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SERPINE1, SRC |
3.07388 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CYP1B1, DRD2, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SRC |
3.04762 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.04762 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.04762 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.04762 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH |
3.04666 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.04484 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.0231 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.01918 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CDC25B, DRD2, ESR1, F3, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIM1 |
3.01828 |
[BP] GO:0007267 |
None
|
ADORA1, AR, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.0015 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.0015 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.0015 |
[BP] GO:0042391 |
None
|
ADORA1, DRD1, GPER1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.98644 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, AR, DRD2, FLT3, GPER1, GRM1, KDR, PTPN1, SRC, XDH |
2.98307 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AR, AXL, CYP1B1, DRD2, F10, F3, FLT3, GPER1, GRM1, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.98307 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, GPER1, GRM5, IGF1R, MMP2, PPARA, SRC, TYR |
2.97586 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.96968 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, SRC, TYR, XDH |
2.96678 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AR, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.95987 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, TYR |
2.88582 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, AR, CDC25B, DRD1, DRD2, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.87895 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.87173 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, GPER1, KDR, MET, PPARA, SERPINE1 |
2.87173 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, GPER1, HCAR2 |
2.86051 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.85029 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AR, AURKB, CDC25B, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, IGF1R, MMP9, PTPN1, SERPINE1, SRC, XDH |
2.82627 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.79474 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, GPER1, GRM3, GRM8, PPARA |
2.78012 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.7783 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, AR, CDC25B, DRD2, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.77813 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AR, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.75966 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.71192 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, ESRRB, GPER1, GRM3, GRM8, PPARA |
2.71192 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, GPER1, GRM5, IGF1R, MMP2, PPARA, SRC, TYR |
2.70435 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AR, AURKB, CDC25B, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.66712 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, DRD1, DRD2, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PTPN1, SERPINE1, SRC, XDH |
2.66712 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, AXL, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SLC1A1, SRC, TYR, XDH |
2.66261 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, DRD1, DRD2, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PTPN1, SERPINE1, SRC, XDH |
2.6559 |
[BP] GO:0023052 |
None
|
ADORA1, AR, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.64784 |
[BP] GO:0030817 |
None
|
DRD1, DRD2, GPER1, GRM3, GRM8 |
2.64546 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.64546 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.60636 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, GPER1, SRC |
2.59361 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, GPER1, GRIK5, SLC1A1 |
2.57964 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, IGF1R, KDR, MMP9, PIM1, PTPN1, SERPINE1, SRC |
2.55575 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, CYP19A1, DRD1, DRD2, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.55379 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, AR, DRD2, FLT3, GPER1, GRM1, IGF1R, KDR, PTPN1, SRC, XDH |
2.55293 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.50935 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, GPER1, HCAR2, PPARA, SRC |
2.50276 |
[BP] GO:0007154 |
None
|
ADORA1, AR, AXL, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.49764 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.48437 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.46923 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.45665 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.45665 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.45665 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AR, AXL, CA2, CYP1B1, DRD2, ESRRB, F3, GPER1, HCAR2, KDR, MET, MMP9, PIM1, SERPINE1, SLC1A1, SRC |
2.42154 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AR, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.41947 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.41373 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
2.38347 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, GPER1, PPARA, SERPINE1 |
2.38092 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.38092 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.37559 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AR, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.37132 |
[BP] GO:0030814 |
None
|
DRD1, DRD2, GPER1, GRM3, GRM8 |
2.35725 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AR, AURKB, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, GPER1, GRM1, GRM5, MET, MMP9, PTPN1, SRC, XDH |
2.33569 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.32761 |
[BP] GO:0030802 |
None
|
DRD1, DRD2, GPER1, GRM3, GRM8 |
2.31203 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.30858 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.28967 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, ESR1, GPER1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.27607 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, DRD2, F10, F3, MET, SERPINE1, XDH |
2.26794 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, ESR1, FABP4, GPER1, MMP2, PPARA, PTPN1, SERPINE1, SRC |
2.25653 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SRC |
2.25653 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23948 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.23419 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.23097 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2 |
2.23044 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.22943 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
2.22943 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22943 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.22943 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22943 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AR, AURKB, AXL, CA2, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, SERPINE1, SRC, TYR |
2.21705 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21149 |
[BP] GO:1900371 |
None
|
DRD1, DRD2, GPER1, GRM3, GRM8 |
2.19109 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, GPER1, GRM1, GRM5 |
2.1829 |
[BP] GO:0030808 |
None
|
DRD1, DRD2, GPER1, GRM3, GRM8 |
2.17865 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.1555 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DRD2, ESR1, F3, FABP4, GPER1, IGF1R, MET, MMP2, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.15064 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.13614 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AR, AURKB, AXL, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.13614 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AR, DRD1, ESR1, FLT3, GPER1, GRM5, IGF1R, MMP2, SRC |
2.12367 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.12367 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.12367 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AR, AURKB, AXL, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GRM3, GRM8, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SERPINE1, SRC, XDH |
2.10337 |
[BP] GO:1900543 |
None
|
DRD2, GRM3, GRM8, PPARA |
2.09735 |
[BP] GO:0045980 |
None
|
DRD2, GRM3, GRM8, PPARA |
2.07528 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, GPER1, GRIK5, GRM5, HCAR2, MMP9, PPARA, PTPN1, SERPINE1, SRC |
2.07077 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.04735 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.04735 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.04735 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.04735 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.04735 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.04353 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.04353 |
[BP] GO:0030799 |
None
|
DRD1, DRD2, GPER1, GRM3, GRM8 |
2.0325 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, GRM1, MMP2, PPARA, SRC, TYR |
2.0325 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AR, AURKB, AXL, DRD2, ESR1, GPER1, IGF1R, KDR, MET, MMP1, MMP9, SERPINE1, SRC |
2.00695 |
[CC] GO:0042734 |
None
|
GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.70404 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA9, DRD1, DRD2, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
4.50064 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
4.10103 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
4.10103 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, AR, AXL, CA12, CA14, CA2, CA9, DRD1, DRD2, ESR1, F10, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SERPINE1, SLC1A1, SRC |
3.75865 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F10, F3, FLT3, GPER1, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 |
3.66509 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, DRD2, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
3.27897 |
[CC] GO:0097060 |
None
|
GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.0873 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, AXL, CA2, CA9, DRD1, DRD2, F10, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SRC |
2.87173 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, AR, AXL, CA12, CA14, CA2, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SERPINE1, SLC1A1, SRC, TYR |
2.87173 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, DRD1, DRD2, FLT3, GPER1, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 |
2.80571 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, AXL, CA12, CA14, CA2, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KDR, MET, PTPN1, SLC1A1, SRC, TYR |
2.45193 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.32761 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.29853 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, DRD2, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC |
2.23311 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, F10, FLT3, GPER1, GRIA2, HSD17B2, PTPN1 |
2.15064 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TYR, XDH |
15.851 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
14.7785 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.02098 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA |
8.65275 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.22454 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.14651 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
8.14602 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA |
7.75731 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, SHBG |
7.74101 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA |
7.53242 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SLC1A1, SRC, TYR, XDH |
7.28651 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA |
6.96806 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1 |
6.9192 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.9192 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
6.86243 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.62978 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.62978 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SLC1A1, TYR, XDH |
6.23904 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
6.16284 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.16284 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPER1, HSD17B1, PPARA, SHBG |
5.51702 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.36988 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
5.30384 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.3032 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
5.24271 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
5.1915 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET |
5.1915 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, F10, F3, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TYR, XDH |
5.15474 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.14303 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, SLC1A1, TYR, XDH |
4.88175 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
4.77687 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
4.59911 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.5347 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.06499 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, IGF1R, SHBG |
4.02513 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, SRC, XDH |
3.91461 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.4186 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.2802 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.0231 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.00454 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC |
2.87173 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85029 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85029 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75966 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.46923 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.45712 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.45665 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.45665 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.45392 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.45392 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22943 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.22943 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.22943 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.22943 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.22943 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.04735 |